Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 17, 144-147, February 1, 1957]
© 1957 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, B. R.
Right arrow Articles by Jordan, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, B. R.
Right arrow Articles by Jordan, R. T.

Serum Lactic Dehydrogenase Activity in Mice with Transplantable Leukemia*

Borroughs R. Hill and Russell T. Jordan{dagger}

( Departments of Biochemistry and Microbiology, Division of Research, City of Hope Medical Research Institute, Duarte, Calif.)

1. Two different sublines of AKR mice varying in susceptibility to the lethal effects of the L4946 transplantable leukemia of mice were studied to determine the level of serum lactic acid dehydrogenase (SLDH) following transplantation of tumor cells by various routes.
2. All mice given injections intracerebrally, intraperitoneally, and subcutaneously showed a rise in serum lactic dehydrogenase as early as 48 hours following inoculation, at a time when tumor growth was not palpable or detectable by hematological or cytological examination.
3. In mice uniformly susceptible to the lethal effects of the tumor cells, serum lactic dehydrogenase activity increased until the animals died and showed a marked rise just before death.
4. In mice bearing tumors which grew and then regressed following transplantation, an initial rise in serum lactic dehydrogenase occurred which gradually returned to within normal limits when the tumor disappeared.
5. The results indicate that serum lactic dehydrogenase activity is a sensitive indicator for determining the growth, development, and regression of the L4946 transplantable lymphatic leukemia in AKR mice.

* Project supported by Grant No. C-2641, U.S. Public Health Service.

{dagger} Clinical Assistant Professor, Dept. Infectious Diseases, University of California School of Medicine, Los Angeles.

Received 11/16/56.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1957 by the American Association for Cancer Research.